NOVARTIS logo.jpg
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
31 mars 2023 07h53 HE | Novartis Pharma AG
If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to <18 years in the European Union Pediatric...
MicrosoftTeams-image (5).png
Cardiology Stem Cells Market Revenue to Hit USD 5.1 Bn by 2031 | Transparency Market Research
16 mars 2023 09h00 HE | Transparency Market Research
Wilmington, Delaware, United States, March 16, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research study, the global cardiology stem cells market stood at US$ 2.6 Bn in 2022, and it...
MicrosoftTeams-image (5).png
Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study
07 mars 2023 14h30 HE | Transparency Market Research
Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
logo 600X600.png
Global Tonometry Device Market to Surpass US$ 176.02 Million by 2030, Says Coherent Market Insights (CMI)
13 févr. 2023 09h15 HE | CMI
Burlingame, Feb. 13, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global tonometry device market is estimated to be valued at US$ 109.68 million in 2022 and is expected to...
Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction
09 janv. 2023 08h00 HE | Imbria Pharmaceuticals Inc.
BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today announced...
Global Atrial Fibrillation Treatment Market
Outlook on the Atrial Fibrillation Treatment Global Market to 2027 - Rising Prevalence of Cardiovascular Diseases Drives Growth
22 déc. 2022 06h38 HE | Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
BodiGuide Inc. Announces Technology Breakthrough; Revolutionary New Device Continuously Measures Edema
07 déc. 2022 09h00 HE | BodiGuide
BELLEVUE, Wash., Dec. 07, 2022 (GLOBE NEWSWIRE) -- BodiGuide Inc. today announced a new technology capable of continuously measuring leg edema and quantifying fluid retention has been developed by...
$4.5+ Billion Artificial Heart Market Size to Exhibit CAGR of 15+% by 2028, Deep Dive Analysis of Key Players and Growth Opportunities
12 oct. 2022 09h16 HE | The Insight Partners
New York, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Insight Partners recently published a report on "Artificial Heart Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact...
Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting
03 oct. 2022 07h00 HE | Nuwellis, Inc.
MINNEAPOLIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the results...
American Society of
American Society of Echocardiography Invests in Joint Research Initiative to Help Patients Suffering from Wide-Reaching Form of Heart Failure
29 sept. 2022 09h30 HE | American Society of Echocardiography
Durham, NC, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around...